PA
CXW icon

PharVision Advisers’s CoreCivic CXW Stock Holding History

PharVision Advisers’s Portfolio CXW Stock Details CXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,178
Closed -$320K – 687
2025
Q2 		$320K Buy
+15,178
New +$327K 0.46% 69
2025
Q1 		– Sell
-40,426
Closed -$879K – 325
2024
Q4 		$879K Buy
+40,426
New +$740K 0.74% 4

Other funds holding CXW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

PharVision Advisers's CXW Position: Q3 2025 in Review

PharVision Advisers sold out of CoreCivic (CXW) in Q3 2025, closing a stake of 15,178 shares — an estimated $320K sold.

PharVision Advisers first reported a position in CXW in Q4 2024 and held it in 2 quarters. The position peaked at $879K in Q4 2024. 243 funds tracked by Wall St. Rank hold CXW as of Q3 2025.

  • PharVision Advisers reported no remaining CoreCivic position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 15,178 CoreCivic shares in Q3 2025, an estimated $320K.
  • PharVision Advisers first reported a position in CoreCivic in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's CoreCivic position peaked at $879K in Q4 2024.
  • 243 funds tracked by Wall St. Rank held CoreCivic as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.